Table 2. Summary of included publications.
First author (year of publication) | Country (total n) | Study design | Population | Sample size | Timing of antibiotic exposure | Outcome | Result |
---|---|---|---|---|---|---|---|
Baron et al. [26], (2020) | United States (3), Denmark (2), Canada (2), Japan (1), Iran (1), the Netherlands (1), Sweden (1) and Finland (1) | Systematic review | 0–5 years until 7–14 years | 134 (minimum) to 910,301 participants (maximum) | Pre- and perinatal | Asthma | Positive |
Denmark (1), United States (1) and Belgium (1) | Systematic review | 18 months up to 4 years of age | 492 (minimum) to 62,560 participants (maximum) | Pre- and perinatal | Eczema | Positive | |
Higgins et al. [20], (2021) | Isle of Wight, UK | Prospective birth cohort | 0–12 months | 412 participants | Pre- and perinatal | Infant wheezing | Negative |
Cassidy-Bushrow et al. [28], (2018) | Detroit, US | Retrospective | 0–2 years | 527 participants | Prenatal | Early BMI Index | Positive |
Baron et al. [29], (2020) | United States (4) and Denmark (1) | Systematic review | 2 years old up to of 7 years old | 436 (minimum) to 39,615 mother-child pairs (maximum) | Pre- and perinatal | Overweight | Positive (under certain conditions) |
Cunha et al. [14], (2021) | Portugal | Retrospective | 0–4 years | 7,459 participants | Pre- and perinatal | Different infections: tonsillitis, otitis, pneumonia, UTI, AGE, H. pylori | Tonsillitis: positive |
Otitis: negative | |||||||
Pneumonia: negative | |||||||
UTI: negative | |||||||
AGE: negative | |||||||
H. pylori: negative | |||||||
Hamad et al. [36], (2019) | Manitoba, Canada | Population-based cohort | 0–13 years old | 214,834 participants | Pre- and perinatal | Autism spectrum disorders | Positive |
Huang et al. [27], (2020) | Sweden (1), Poland (1), Belgium (2), South Korea (1), UK (1), Denmark (1) | Meta-analysis | 0–1 years old | 411 (minimum) to 62,560 participants (maximum) | Pre- and perinatal | Eczema | Positive only in first and second trimesters |
Jess et al. [33], (2019) | Denmark | Population-based nationwide cohort | 7–11 years old | 43,365 mother-child pairs | Pre- and perinatal | Overweight | Negative |
Leong et al. [32], (2020) | New Zealand | Cross-sectional national | 0–4 years old | 151,359 participants | Pre- and perinatal | Obesity | Negative |
Loewen et al. [23], (2018) | Winnipeg, Canada | Population-based | 0–9 years old | 213,661 mother-child pairs | Pre- and perinatal | Asthma | Positive (and doseresponse association) |
Metsälä et al. [21], (2015) | Finland | Population- and register-based nested case–control study | 3–11 years old | 6,690 case-control pairs | Prenatal | Asthma | Positive |
Metz et al. [35], (2020) | USA | Retrospective cohort | 2–5 years old | 4,825 mother-child pairs | Perinatal | BMI | Negative |
Metzler et al. [25], (2019) | Austria, Finland, France, Germany, and Switzerland | Prospective birth cohort | 0–6 years old | 1,080 participants | Prenatal | AD, food allergy, asthma, atopic sensitization and allergic rhinitis | AD: positive Food allergy: positive |
Asthma: negative Atopic sensitization: negative | |||||||
Allergic rhinitis: negative | |||||||
Miller et al. [16], (2018) | Denmark | Population-based cohort | 0–14 years old | 443,546 participants | Pre- and perinatal | Infection-related hospitalization | Positive |
Mor et al. [30], (2015) | Denmark | Prevalence | 7–16 years old | 9,886 participants | Pre- and perinatal | Overweight and obesity | Positive |
Mulder et al. [22], (2016) | The Netherlands | Case-sibling and case-control | 0–5 years old | 2,456 participants | Pre- and perinatal | Asthma | Case-sibling: positive only 3rd trimester |
Case-control study: positive in any trimester | |||||||
Örtqvist et al. [17], (2019) | Sweden | Population-based | 0–6 years old | 827,239 participants | Pre- and perinatal | IBD | Positive |
Pedersen et al. [15], (2017) | Denmark | Birth cohort | 0–3 years old | 514 (OM) and 699 (VT) participants | Pre- and perinatal | OM and VT | OM: positive (and doseresponse association) |
VT: positive | |||||||
Timm et al. [18], (2017) | Denmark | Birth cohort | 18 months old | 62,560 mother-child pairs | Prenatal | AD | Positive |
Turi et al. [24], (2021) | Tennessee (United States) | Population-based cohort | 0–8 years old | 84,214 mother-child pairs | Pre- and perinatal | Asthma | Positive (and dose-response association) |
Wan et al. [31], (2020) | Hungary, South Korea, Denmark, New Zealand, UK, Canada, United States, Finland, The Netherlands | Systematic review and meta-analysis | 0–11 years old | 1,253,035 participants total | Pre- and perinatal | Childhood overweight and obesity | Negative |
Wohl et al. [19], (2015) | Pennsylvania (United States) | Retrospective analysis | 0–2 years old | 492 mother-child pairs | Prenatal | AD | Positive |
OM: otitis media, VT: ventilation tubes, BMI: body mass index, UTI: urinary tract infection, AGE: acute gastroenteritis, AD: atopic dermatitis, IBD: inflammatory bowel disease, H. pylori: Helicobacter pylori.